My Treatment Approach: Identifying and Managing Immune Effector Cell-Associated Enteritis/Colitis (IEC-EC) Following CAR TCell Therapy in Relapsed/Refractory Multiple Myeloma
Advertisement
My Treatment Approach: Identifying and Managing Immune Effector Cell-Associated Enteritis/Colitis (IEC-EC) Following CAR TCell Therapy in Relapsed/Refractory Multiple Myeloma
In this segment the panelists, Dr. Samir Parekh and Dr. Saurabh Mehandru, both of Mount Sinai in New York, open their discussion of gastrointestinal toxicity following anti-B-cell maturation antigen chimeric antigen receptor (CAR) T-cell therapy for relapsed multiple myeloma.
In this segment the panelists, Dr. Samir Parekh and Dr. Saurabh Mehandru, of Mount Sinai in New York, work through the diagnostic approach to persistent diarrhea after chimeric antigen receptor (CAR) T-cell therapy for relapsed multiple myeloma.
